Stephen J. Rozzo

Evidence for an Interferon-Inducible Gene, Ifi202, in the Susceptibility to Systemic Lupus

Stephen J. Rozzo, John Allard, Divaker Choubey et al. · Immunity · 2001 · 360 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL

Kenneth B. Gordon, Kim Papp, Yves Poulin et al. · Journal of the American Academy of Dermatology · 2011 · 177 citations

Life Sciences, Dermatology, Immunology +11

Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase <scp>III</scp> clinical trials (re <scp>SURFACE</scp> 1 and re <scp>SURFACE</scp> 2) through 148 weeks

Kristian Reich, Richard B. Warren, Lars Iversen et al. · British Journal of Dermatology · 2019 · 143 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.

Charles G. Drake, Stephen J. Rozzo, HERMAN HIRSCHFELD et al. · The Journal of Immunology · 1995 · 142 citations

Life Sciences, Genetics, Immunology +15

Aging-Dependent Exclusion of Antigen-Inexperienced Cells from the Peripheral B Cell Repertoire

Sara A. Johnson, Stephen J. Rozzo, John C. Cambier · The Journal of Immunology · 2002 · 136 citations

Life Sciences, Cell Biology, Immunology +15